David J. Cohen, MD, FSCAI

Director of Clinical and Outcomes Research
Cardiovascular Research Foundation
New York, New York, United States

Dr. Cohen is currently Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation, Director of Academic Affairs at St. Francis Hospital, and faculty member at Columbia University. Dr. Cohen is an interventional and structural cardiologist with more than 25 years of experience in the field. Dr. Cohen’s research focuses on the application of formal cost-effectiveness methodology to novel interventions for the diagnosis and treatment of cardiovascular disease and the extension of traditional cardiovascular outcomes research to include collection of patient-centered outcomes among patients undergoing treatment for cardiovascular disease. He is also active in research to determine the short- and long-term outcomes of new devices for percutaneous coronary revascularization and identifying the optimal target populations and techniques for these devices.

Presentation(s):

• CARDIOTUBE INTERVIEW: New mitral replacement technology Innovalve and others

  Saturday, February 25, 2023
  4:00 PM – 4:10 PM ET

  Disclosure information not submitted.

• CARDIOTUBE INTERIVEW: Women in interventional cardiology are we closing the gap the European view

  Saturday, February 25, 2023
  4:15 PM – 4:25 PM ET

  Disclosure information not submitted.

• CARDIOTUBE INTERIVEW: Management of the pregnant women in the caath lab

  Saturday, February 25, 2023
  4:30 PM – 4:40 PM ET

  Disclosure information not submitted.

• CARDIOTUBE INTERVIEW: PPM small annulus and the smart trial

  Saturday, February 25, 2023
  4:45 PM – 4:55 PM ET

  Disclosure information not submitted.

• CARDIOTUBE INTERVIEW: LBT Interview: Watchman FLX one year result

  Saturday, February 25, 2023
  5:00 PM – 5:10 PM ET

  Disclosure information not submitted.

• CARDIOTUBE INTERVIEW: LBT Interview: Biomag 6 Months results

  Saturday, February 25, 2023
  5:15 PM – 5:25 PM ET

  Disclosure information not submitted.

• OPTIMIZATION OF ANTICOAGULATION THERAPY FOR ACS PATIENTS

  Saturday, February 25, 2023
  6:00 PM – 7:55 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

• Panel Discussion

  Saturday, February 25, 2023
  6:46 PM – 7:00 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

• Panel Discussion: Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy – Personalizing Treatment to Optimize Outcomes

  Saturday, February 25, 2023
  7:40 PM – 7:55 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

• Tricuspid Valve Interventions-- Will They Be Cost-Effective?

  Sunday, February 26, 2023
  5:15 PM – 5:23 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

• Panel Discussion: How Should We Proceed With Tricuspid Valve Interventions and When Should We Intervene?

  Sunday, February 26, 2023
  5:45 PM – 6:00 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

• LATE-BREAKING TRIALS | SESSION THREE

  Monday, February 27, 2023
  11:30 AM – 12:30 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

• CEREBRAL EMBOLIC PROTECTION DEVICES

  Monday, February 27, 2023
  1:30 PM – 2:25 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

• Embolic Protection for TAVR-- A Skeptics Perspective

  Monday, February 27, 2023
  1:54 PM – 2:02 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

• Meaningful Endpoints for TV Intervention Trials: What Does Study Success Look Like?

  Monday, February 27, 2023
  2:16 PM – 2:24 PM ET

  Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)